What is the recommended DVT prophylaxis for a patient undergoing surgery for an upper tibial (tibial plateau) fracture?

DVT Prophylaxis for Upper Tibial (Tibial Plateau) Fracture Surgery

All patients undergoing surgery for tibial plateau fractures should receive pharmacological DVT prophylaxis with low-molecular-weight heparin (LMWH), specifically enoxaparin 30 mg subcutaneously every 12 hours or 40 mg once daily, starting preoperatively and continuing for a minimum of 10-14 days postoperatively, with strong consideration for extended prophylaxis up to 35 days in high-risk patients. 1, 2

Preferred Pharmacological Regimen

LMWH is the preferred agent for tibial plateau fractures, with the first dose administered at least 12 hours before or after surgery to balance efficacy and bleeding risk. 1

Standard Dosing Options:

• Enoxaparin 30 mg subcutaneously every 12 hours (preferred for trauma patients) 2
• Enoxaparin 40 mg subcutaneously once daily (acceptable alternative, particularly for younger patients without additional risk factors) 1, 2
• Dalteparin 5000 IU subcutaneously once daily (alternative LMWH) 1
• Fondaparinux 2.5 mg subcutaneously once daily (alternative if LMWH contraindicated) 1, 2
• Unfractionated heparin 5000 units subcutaneously every 8 hours (reserved for patients with severe renal impairment, CrCl <30 mL/min) 1, 2

Duration of Prophylaxis

The minimum duration is 10-14 days postoperatively, but tibial plateau fractures carry substantial VTE risk that extends well beyond hospital discharge. 1

Extended Prophylaxis (Up to 35 Days) Should Be Strongly Considered For:

• Restricted mobility or prolonged non-weight-bearing status 2
• Obesity (BMI >30) 2
• History of prior VTE 2
• Active malignancy 2
• Age >75 years 2
• Complex fractures (AO/OTA type C, especially C3) 3, 4
• High-energy trauma mechanisms 4
• Associated compartment syndrome or dislocation 4

Extended prophylaxis with LMWH reduces postdischarge VTE by approximately two-thirds after major lower extremity orthopedic surgery, though the absolute reduction in fatal PE is modest (approximately 1 per 2,500 patients). 5

Mechanical Prophylaxis as Adjunct

Intermittent pneumatic compression (IPC) devices should be added to pharmacologic prophylaxis in high-risk patients, applied for at least 18 hours daily and continued throughout hospitalization. 1, 2

Mechanical Prophylaxis Alone Is Indicated Only When:

• Active bleeding 2
• Severe thrombocytopenia (platelet count <50,000/μL) 2
• Coagulopathy (INR >1.5) 2
• Hemodynamic instability 2
• Recent neurosurgery or active intracranial bleeding 2

When pharmacologic prophylaxis is contraindicated, use IPC devices until bleeding risk diminishes, then initiate pharmacologic agents. 1, 2

Special Populations and Dose Adjustments

Renal Impairment:

• Severe renal insufficiency (CrCl <30 mL/min): Avoid LMWH; use unfractionated heparin 5000 units subcutaneously every 8 hours instead 2
• Moderate renal impairment (CrCl 30-50 mL/min): Reduce fondaparinux to 1.5 mg daily if using this agent 1
• Monitor anti-Xa levels in patients with renal dysfunction receiving LMWH to prevent bleeding 2

Obesity:

• Body weight >150 kg: Consider increasing enoxaparin to 40 mg subcutaneously every 12 hours 1, 2

Elderly Patients:

• Age >65 years: Use enoxaparin 30 mg every 12 hours as initial dose 2
• Age ≥70 years with renal insufficiency: Avoid tinzaparin due to increased mortality risk 2

Critical Timing Considerations

Start prophylaxis as soon as possible after injury, even before definitive surgical fixation, unless absolute contraindications exist. 2 Tibial plateau fractures have a 23.6% incidence of unapparent preoperative DVT despite prophylactic anticoagulation, particularly in high-energy trauma with severe fractures and soft tissue injuries. 4

For patients requiring staged surgery with temporary external fixation, continue prophylaxis throughout the entire treatment period until definitive fixation and mobilization are achieved. 4

Common Pitfalls to Avoid

• Undertreatment is common: Approximately 42-58% of at-risk orthopedic trauma patients do not receive appropriate VTE prophylaxis despite clear guidelines. 2
• Do not discontinue prophylaxis at hospital discharge for high-risk patients; extended prophylaxis up to 35 days significantly reduces postdischarge VTE. 1, 5
• Do not rely on aspirin alone: Aspirin 81 mg twice daily is acceptable only in lower-risk patients without additional VTE risk factors, but LMWH is strongly preferred. 2
• Do not use IVC filters for primary prophylaxis: Filters are not recommended for routine VTE prevention in trauma patients. 1, 2
• Do not perform routine surveillance ultrasonography: Screening asymptomatic patients is not recommended. 1, 2
• Pharmacologic prophylaxis prevents approximately 10 times as many nonfatal VTE events as it causes nonfatal bleeding complications in trauma patients, strongly favoring its use. 2

Algorithm for High-Risk Features

If the patient has ≥2 of the following, extend prophylaxis to 28-35 days:

• Complex fracture pattern (AO/OTA type C) 3, 4
• High-energy mechanism 4
• Associated compartment syndrome or dislocation 4
• Prolonged immobilization with external fixator 4
• Age >75 years 2
• BMI >30 2
• History of VTE 2
• Active malignancy 2